These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6441959)

  • 21. Therapeutic frontiers in Alzheimer's disease.
    Miller SW; Mahoney JM; Jann MW
    Pharmacotherapy; 1992; 12(3):217-31. PubMed ID: 1608856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Laboratory diagnostic tests for Alzheimer's disease.
    Iqbal K; Wang GP; Grundke-Iqbal I; Wisniewski HM
    Prog Clin Biol Res; 1989; 317():679-87. PubMed ID: 2690116
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
    Grossmann WM; Standl A; May U; van Laak HH; Hirche H
    Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa.
    Davies P; Katzman R; Terry RD
    Nature; 1980 Nov; 288(5788):279-80. PubMed ID: 6107862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of mania with the cholinomimetic agent RS 86.
    Krieg JC; Berger M
    Br J Psychiatry; 1986 May; 148():613. PubMed ID: 3535973
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of cholinergic and anticholinergic drugs on short-term memory in Alzheimer's dementia: a neuropsychological and computerized electroencephalographic study.
    Agnoli A; Martucci N; Manna V; Conti L; Fioravanti M
    Clin Neuropharmacol; 1983; 6(4):311-23. PubMed ID: 6661730
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel pharmacologic approaches to the treatment of senile dementia of the Alzheimer's type (SDAT).
    Reisberg B; London E; Ferris SH; Anand R; de Leon MJ
    Psychopharmacol Bull; 1983; 19(2):220-5. PubMed ID: 6346374
    [No Abstract]   [Full Text] [Related]  

  • 28. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
    Parnetti L; Amenta F; Gallai V
    Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential responsivity of mood, behavior, and cognition to cholinergic agents in elderly neuropsychiatric populations.
    Sunderland T; Tariot PN; Newhouse PA
    Brain Res; 1988 Dec; 472(4):371-89. PubMed ID: 3066441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential role of muscarinic agonists in Alzheimer's disease.
    Avery EE; Baker LD; Asthana S
    Drugs Aging; 1997 Dec; 11(6):450-9. PubMed ID: 9413702
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of Alzheimer's disease with cholinergic drugs.
    Kumar V; Calache M
    Int J Clin Pharmacol Ther Toxicol; 1991 Jan; 29(1):23-37. PubMed ID: 2004862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment issues in clinical trials of tetrahydroaminoacridine and studies to alter decline in Alzheimer disease.
    Thal LJ
    Alzheimer Dis Assoc Disord; 1991; 5 Suppl 1():S37-9. PubMed ID: 1781972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differences in ventricle dilation and clinical findings between the early- and late-onset subtypes of Alzheimer's dementia].
    Kono K; Yamamoto T; Kuzuya F; Endo H
    Nihon Ronen Igakkai Zasshi; 1991 May; 28(3):358-64. PubMed ID: 1895530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Memory enhancement with oral physostigmine in Alzheimer's disease.
    N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388
    [No Abstract]   [Full Text] [Related]  

  • 35. Senile dementia of the Alzheimer type.
    Erwin WG
    Clin Pharm; 1984; 3(5):497-504. PubMed ID: 6149031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholinergic muscarinic binding by human lymphocytes: changes with aging, antagonist treatment, and senile dementia of the Alzheimer type.
    Rabey JM; Shenkman L; Gilad GM
    Ann Neurol; 1986 Nov; 20(5):628-31. PubMed ID: 3789676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cerebral glucose metabolism in presenile dementia of the Alzheimer type--follow-up of therapy with muscarinergic choline agonists].
    Szelies B; Herholz K; Pawlik G; Beil C; Wienhard K; Heiss WD
    Fortschr Neurol Psychiatr; 1986 Nov; 54(11):364-73. PubMed ID: 3492415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Milacemide: a placebo-controlled study in senile dementia of the Alzheimer type.
    Dysken MW; Mendels J; LeWitt P; Reisberg B; Pomara N; Wood J; Skare S; Fakouhi JD; Herting RL
    J Am Geriatr Soc; 1992 May; 40(5):503-6. PubMed ID: 1634705
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple-dose arecoline infusions in Alzheimer's disease.
    Tariot PN; Cohen RM; Welkowitz JA; Sunderland T; Newhouse PA; Murphy DL; Weingartner H
    Arch Gen Psychiatry; 1988 Oct; 45(10):901-5. PubMed ID: 3048224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease.
    Woolf NJ; Jacobs RW; Butcher LL
    Neurosci Lett; 1989 Jan; 96(3):277-82. PubMed ID: 2717053
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.